A surveillance of high-level gentamicin-resistant enterococcal bacteremia

Journal of Infection and Chemotherapy

Volumn 17, Issue 3, 2011, Pages 433-434

  Araoka, Hideki ^a   Kimura, Muneyoshi ^a   Yoneyama, Akiko ^a  

^a TORANOMON HOSPITAL   (Japan)

Author keywords

Bacteremia; Endocarditis; Enterococci; Gentamicin resistance

Indexed keywords

AMPICILLIN; CEFTRIAXONE; GENTAMICIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL ENDOCARDITIS; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BLOOD CULTURE; CONTROLLED STUDY; DISEASE SEVERITY; DISEASE SURVEILLANCE; ENTEROCOCCAL BACTEREMIA; ENTEROCOCCAL ENDOCARDITIS; ENTEROCOCCAL INFECTION; ENTEROCOCCUS AVIUM; ENTEROCOCCUS CASSELIFLAVUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM; EPSILOMETER TEST; HUMAN; JAPAN; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; MORBIDITY; MORTALITY; NONHUMAN; PROGNOSIS; RETROSPECTIVE STUDY;

EID: 80051590980     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1007/s10156-010-0175-0     Document Type: Article

References (10)

1. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24, 179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39:309-17. (Pubitemid 39050477)
2. Lodise TP, McKinnon PS, Tam VH, Rybak MJ. Clinical outcomes for patients with bacteremia caused by vancomycinresistant enterococcus in a level 1 trauma center. Clin Infect Dis. 2002;34:922-9. (Pubitemid 34229760)
3. Arias CA, Contreras GA, Murray BE. Management of multidrugresistant enterococcal infections. Clin Microbiol Infect. 2010;16:555-62.
4. Murray BE. The life and times of the Enterococcus. Clin Microbiol Rev. 1990;3:46-65. (Pubitemid 20078774)
5. Chow JW. Aminoglycoside resistance in enterococci. Clin Infect Dis. 2000;31:586-9. (Pubitemid 32289595)
6. Shaked H, Carmeli Y, Schwartz D, Siegman-Igra Y. Enterococcal bacteraemia: epidemiological, microbiological, clinical and prognostic characteristics, and the impact of high level gentamicin resistance. Scand J Infect Dis. 2006;38:995-1000. (Pubitemid 44869270)
7. Caballero-Granado FJ, Cisneros JM, Luque R, Torres-Tortosa M, Gamboa F, Díez F, et al. Comparative study of bacteremias caused by Enterococcus spp. with and without high-level resistance to gentamicin. The Grupo Andaluz para el estudio de las Enfermedades Infecciosas. J Clin Microbiol. 1998;36:520-5. (Pubitemid 28060323)
8. Watanakunakorn C, Patel R. Comparison of patients with enterococcal bacteremia due to strains with and without highlevel resistance to gentamicin. Clin Infect Dis. 1993;17:74-8. (Pubitemid 23197568)
9. Gavaldà J, Len O, Miró JM, Muñoz P, Montejo M, Alarcón A, et al. Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone. Ann Intern Med. 2007;146:574-9. (Pubitemid 351650538)
10. Jang HC, Lee S, Song KH, Jeon JH, Park WB, Park SW, et al. Clinical features, risk factors and outcomes of bacteremia due to enterococci with high-level gentamicin resistance: comparison with bacteremia due to enterococci without high-level gentamicin resistance. J Korean Med Sci. 2010;25:3-8.